Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2023.
Related news for (OMIC)
- Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
- Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
- Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference